AIMC Topic: Drug Discovery

Clear Filters Showing 811 to 820 of 1689 articles

From traditional to data-driven medicinal chemistry: A case study.

Drug discovery today
Artificial intelligence (AI) and data science are beginning to impact drug discovery. It usually takes considerable time and efforts until new scientific concepts or technologies make a transition from conceptual stages to practical applicability and...

Multimodal molecular imaging in drug discovery and development.

Drug discovery today
In addition to individual imaging techniques, the combination and integration of several imaging techniques, so-called multimodal imaging, can provide large amounts of anatomical, functional, and molecular information accelerating drug discovery and ...

Prediction of In Vivo Pharmacokinetic Parameters and Time-Exposure Curves in Rats Using Machine Learning from the Chemical Structure.

Molecular pharmaceutics
Animal pharmacokinetic (PK) data as well as human and animal in vitro systems are utilized in drug discovery to define the rate and route of drug elimination. Accurate prediction and mechanistic understanding of drug clearance and disposition in anim...

Improving Predictions with a Multitask Convolutional Siamese Network.

Journal of chemical information and modeling
The lead optimization phase of drug discovery refines an initial hit molecule for desired properties, especially potency. Synthesis and experimental testing of the small perturbations during this refinement can be quite costly and time-consuming. Rel...

Machine Learning guided early drug discovery of small molecules.

Drug discovery today
Machine learning (ML) approaches have been widely adopted within the early stages of the drug discovery process, particularly within the context of small-molecule drug candidates. Despite this, the use of ML is still limited in the pharmacokinetic/ph...

SSGraphCPI: A Novel Model for Predicting Compound-Protein Interactions Based on Deep Learning.

International journal of molecular sciences
Identifying compound-protein (drug-target, DTI) interactions (CPI) accurately is a key step in drug discovery. Including virtual screening and drug reuse, it can significantly reduce the time it takes to identify drug candidates and provide patients ...

Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery engine.

Aging
Aging biology is a promising and burgeoning research area that can yield dual-purpose pathways and protein targets that may impact multiple diseases, while retarding or possibly even reversing age-associated processes. One widely used approach to cla...

Evolution of Support Vector Machine and Regression Modeling in Chemoinformatics and Drug Discovery.

Journal of computer-aided molecular design
The support vector machine (SVM) algorithm is one of the most widely used machine learning (ML) methods for predicting active compounds and molecular properties. In chemoinformatics and drug discovery, SVM has been a state-of-the-art ML approach for ...

Artificial Intelligence Technologies for COVID-19 De Novo Drug Design.

International journal of molecular sciences
The recent covid crisis has provided important lessons for academia and industry regarding digital reorganization. Among the fascinating lessons from these times is the huge potential of data analytics and artificial intelligence. The crisis exponent...

Oncological drug discovery: AI meets structure-based computational research.

Drug discovery today
The integration of machine learning and structure-based methods has proven valuable in the past as a way to prioritize targets and compounds in early drug discovery. In oncological research, these methods can be highly beneficial in addressing the di...